These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of gemfibrozil on serum lipids.
    Author: Samuel P.
    Journal: Am J Med; 1983 May 23; 74(5A):23-7. PubMed ID: 6573843.
    Abstract:
    A two-part, multicenter study to assess the clinical efficacy, side effects, and safety of gemfibrozil in 427 patients over treatment durations of up to 13 months showed that this drug markedly reduces the level of serum triglycerides, while moderately lowering total serum cholesterol levels. The high-density lipoprotein cholesterol level was substantially increased, with concomitant decreases in low-density lipoprotein and very low-density lipoprotein cholesterol levels. The drug was generally well tolerated. However, a potential for increasing blood glucose levels was noted and careful monitoring during therapy is recommended.
    [Abstract] [Full Text] [Related] [New Search]